ZimVie Inc. is a global life sciences company in the dental market. The Company develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. The Company works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. In the dental segment, its core services include designing, manufacturing and distributing dental implant systems. The key products in its dental implant systems portfolio include the T3 Implant, Tapered Screw-Vent Implant System, Trabecular Metal Dental Implant, BellaTek Encode Impression System, and Puros Allograft Particulate. The Company markets its products in about 70 countries in North America, Europe, Latin America and Asia.
BörsenkürzelZIMV
Name des UnternehmensZimVie Inc
IPO-datumFeb 14, 2022
CEOMr. Vafa Jamali
Anzahl der mitarbeiter1770
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 14
Addresse4555 Riverside Drive
StadtPALM BEACH GARDENS
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl33410
Telefon18003425454
Websitehttps://www.zimvie.com/en
BörsenkürzelZIMV
IPO-datumFeb 14, 2022
CEOMr. Vafa Jamali
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten